Related Experiment Video
Updated: Aug 13, 2025
Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
Published on: February 23, 2024
[Oncology: what's new in 2022]
Tu Nguyen-Ngoc1, Karim Abdelhamid1, Nils Degrauwe1
1Service d'oncologie médicale, Département d'oncologie, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Abstract:
The past year has brought several innovations in medical oncology, opening up promising new options for many solid tumors, both localized and metastatic. Immunotherapy, a real spearhead of emerging therapies in metastatic diseases, is seeing its use extend to adjuvant and neoadjuvant modalities, particularly in colon and lung cancers. 2022 also sees a great deal of focus on targeted therapies, as well as on antibody-drug conjugates, which creates new standards in both breast and lung cancers. Here we present the major advances in solid tumors.
Insights
Recent innovations in medical oncology offer new treatment options for solid tumors. Immunotherapy and targeted therapies are expanding to adjuvant and neoadjuvant settings, improving outcomes in lung, colon, and breast cancers.
Area of Science:
- Medical Oncology
- Cancer Research
- Therapeutics Development
Context:
- The past year has seen significant advancements in treating solid tumors.
- Innovations address both localized and metastatic disease stages.
Purpose:
- To present major advances in medical oncology for solid tumors.
- Highlight key innovations in immunotherapy and targeted therapies.
Summary:
- Immunotherapy use is expanding into adjuvant and neoadjuvant settings for colon and lung cancers.
- Targeted therapies and antibody-drug conjugates are establishing new standards in breast and lung cancer treatment.
- Focus on novel therapeutic strategies for diverse solid tumors.
Impact:
- These advances provide promising new options for patients with solid tumors.
- Expansion of immunotherapy and targeted treatments signifies progress in cancer care.
- Establishes new benchmarks in the treatment of breast, lung, and colon cancers.
More Related Videos
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:56Treatment Resistant Cancers
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:07Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...